Cencora Inc (COR) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket
 


Cencora Inc   (NYSE: COR)

Cencora Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cencora Inc in the second quarter 2026?
Cencora Inc achieved a return on average equity (ROE) of 109.91 % in its second quarter 2026, this is above COR's average return on equity of 101.39%.
Cencora Inc s equity during the 12 months ending in the second quarter 2026 are valued at $2 billion

ROE has advanced compared to 95.31% in the first quarter 2026, due to net income growth.

Within the Pharmacy Services & Retail Drugstore industry Cencora Inc achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 70 to 87.

What is ROE?




Return On Equity (Mar 31 2026)
II. Quarter
(Dec 31 2025)
I. Quarter
(Sep 30 2025)
IV. Quarter
(Jun 30 2025)
III. Quarter
(Mar 31 2025)
II. Quarter
Y / Y Equity Change 203.86 % 122.07 % 122.07 % 108.38 % -
Y / Y Net Income Change 127.14 % 14.67 % - 41.46 % 70.32 %
Net Income (TTM) in Millions 2,552 1,640 1,568 1,908 1,706
Return On Equity (TTM) 109.91 % 95.31 % 105.87 % 153.8 % 178.95 %
COR's Total Ranking # 87 # 70 # 51 # 28 # 24
Equity (TTM) in Millions 3,585 1,747 1,747 2,210 1,180
Seq. Equity Change 105.2 % 0 % -20.94 % 87.31 % 49.96 %
Seq. Net Income Change 187.84 % - - -3.86 % 45.31 %

Return On Equity Company Ranking
Within: No.
Industry # 1
Sector # 5
Overall # 87

Return On Equity Statistics
High Average Low
953.36 %
101.39 %
4.53 %
(Sep 30 2023)   (Dec 31 2013)





COR Annual Return On Equity (Sep 30 2025)
2025
(Sep 30 2024)
2024
(Sep 30 2023)
2023


Total Equity in Millions 1,747 787 666 0 0
Y / Y Equity Change 122.07 % 18.08 % - - -
Net Income in Millions 1,568 1,519 1,733 0 0
Y / Y Net Income Change 3.2 % -12.31 % - - -
Return On Equity 89.74 % 193.11 % 260.03 % - -





Annual Roe Comment
In 2025 ROE fell to 89.74 %, despite net income growth.


More Return On Equity Ratios
Pharmacy Services & Retail Drugstore Industry Roe Trends and Statistics
Retail Sector Return On Equity Statistics
COR's' Return on Equity at Yahoo Finance
COR's Roe Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for COR's Competitors
Subscribers only: Roe for Cencora Inc 's Suppliers
Subscribers only: Return On Equity for COR's Customers




Companies with similar Return On Equity at Mar 31 2026, within Retail Sector ROE
Pattern Group Inc   134.46 %
Lands End Inc   114.67 %
Home Depot inc   113.30 %
Cencora Inc   109.91 %
Murphy Usa Inc   89.51 %
Sysco Corporation  86.54 %
Costco Wholesale Corp  67.22 %
The Tjx Companies Inc   59.66 %
The Sherwin williams Company  58.23 %
Chewy Inc   57.30 %
Carvana Co   55.44 %
Buckle Inc  47.36 %
W w Grainger Inc   45.72 %
Ulta Beauty Inc   44.77 %
Tractor Supply Co  42.57 %
Cdw Corp  42.37 %
Publix Super Markets Inc   41.45 %
Best Buy Co Inc   40.05 %
Ross Stores Inc   38.42 %
Burlington Stores Inc   37.72 %
Abercrombie and Fitch Co   37.05 %
Sprouts Farmers Market Inc   36.06 %
Dollar Tree Inc   35.90 %
Build a bear Workshop Inc  35.60 %
Dillard s inc   33.82 %
Fastenal Co  33.25 %
Pool Corporation  32.50 %
Envela Corporation  32.00 %
Gigacloud Technology Inc  31.48 %
Victorias Secret and Co   30.94 %


Date modified: 2026-09-12T06:15:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.